Tìm theo
EUR-1008
Thuốc Gốc
Small Molecule
EUR-1008 (Zentase) is a new, zero-overfill, highly-stable, porcine-derived, pancreatic enzyme replacement product (PEP) for the treatment of Exocrine Pancreatic Insufficiency (EPI). EPI results from various diseases such as cystic fibrosis (CF), chronic pancreatitis, pancreatic cancer, cytomegalovirus infection and HIV/AIDS. EPI can also result from surgical procedures, including open gastric bypass, extensive small bowel resection and pancreatectomy.
Cơ Chế Tác Dụng : EUR-1008 (Zentase) is a new, zero-overfill, highly-stable, porcine-derived, pancreatic enzyme replacement product (PEP) for the treatment of Exocrine Pancreatic Insufficiency (EPI). EPI results from various diseases such as cystic fibrosis (CF), chronic pancreatitis, pancreatic cancer, cytomegalovirus infection and HIV/AIDS. EPI can also result from surgical procedures, including open gastric bypass, extensive small bowel resection and pancreatectomy. EUR-1008 is a new orally delivered pancreatic enzyme product consisting of approximately 14 enzymes, coenzymes and cofactors. It is biologically similar to endogenous human pancreatic secretions and is intended to treat malabsorption of fats, proteins, carbohydrates and other essential nutrients in patients with pancreatic insufficiency.
Chỉ Định : Investigated for use/treatment in cystic fibrosis, diet and nutrition, pancreatic disorders, and pediatric indications.
Dữ Kiện Thương Mại
Nhà Sản Xuất
  • Công ty :
    Sản phẩm biệt dược : Zentase
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05356
... loading
... loading